文献速递消化道肿瘤与早癌消化内镜

欧盟成员国结直肠癌筛查的实施表现:来自第二份欧洲筛查报告的数据

Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report.
PubMed 文献 · Gut · 2018-12-10

该横断面研究基于第二份欧盟筛查报告的汇总定量数据,分析欧盟成员国结直肠癌筛查的关键绩效指标(参与率、阳性率、检出率及腺瘤和结直肠癌的阳性预测值),并采用粗估计和随机效应模型合并估计比较不同成员国/地区及筛查方案的趋势。结果显示,采用粪便免疫化学检测(FIT)的國家参与率范围22.8%-71.3%,高于采用愈创木脂粪便隐血试验(gFOBT)的國家(范围4.5%-66.6%);筛查绩效在不同方案间差异较大。

要点

  • FIT筛查参与率范围为22.8%-71.3%,gFOBT筛查参与率范围为4.5%-66.6%。
  • 结肠镜转诊依从性范围为64%-92%,结肠镜完成率范围为92%-99%。
  • FIT方案中进展期腺瘤和结直肠癌的阳性率与检出率均高于gFOBT方案。

核心结论

  • 基于人群的筛查方案间质量指标存在差异,凸显持续监测的重要性,并需按欧盟指南推荐推动质量改进。

研究设计与样本

  • 横断面研究,分析第二份欧盟筛查报告收集的汇总定量数据,涵盖欧盟成员国的结直肠癌筛查方案。

主要发现

  • FIT筛查参与率范围为22.8%-71.3%,gFOBT筛查参与率范围为4.5%-66.6%。
  • 参与率与同地区乳腺癌筛查参与率呈正相关(ρ=0.842,p<0.001)。
  • 结肠镜转诊依从性范围为64%-92%,结肠镜完成率范围为92%-99%。
  • FIT方案中进展期腺瘤和结直肠癌的阳性率与检出率均高于gFOBT方案,且在男性、年龄较大者及首次筛查者中独立于筛查方案。

关键数值与推荐

  • FIT筛查参与率范围22.8%-71.3%,gFOBT筛查参与率范围4.5%-66.6%。
  • 结肠镜转诊依从性范围64%-92%,结肠镜完成率范围92%-99%。
  • 参与率与乳腺癌筛查参与率的相关系数ρ=0.842,p<0.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To present comparative data about the performance of colorectal cancer (CRC) screening programmes in the European Union Member States (EU MSs). DESIGN: Cross-sectional study. We analysed key performance indicators-participation rate, positivity rate (PR), detection rate (DR) and positive predictive value for adenomas and CRC-based on the aggregated quantitative data collected for the second EU screening report. We derived crude and pooled (through a random effects model) estimates to describe and compare trends across different MSs/regions and screening protocols. RESULTS: Participation rate was higher in countries adopting faecal immunochemical test (FIT) (range: 22.8%-71.3%) than in those using guaiac faecal occult blood test (gFOBT) (range 4.5%-66.6%), and it showed a positive correlation (ρ=0.842, p<0.001) with participation in breast cancer screening in the same areas. Screening performance showed a large variability. Compliance with referral for colonoscopy (total colonoscopy (TC)) assessment ranged between 64% and 92%; TC completion rate ranged between 92% and 99%. PR and DR of advanced adenomas and CRC were higher in FIT, as compared with gFOBT programmes, and independent of the protocol among men, older subjects and those performing their first screening. CONCLUSIONS: The variability in the results of quality indicators across population-based screening programmes highlights the importance of continuous monitoring, as well as the need to promote quality improvement efforts, as recommended in the EU guidelines. The implementation of monitoring systems, ensuring availability of data for the entire process, together with initiatives aimed to enhance reproducibility of histology and quality of endoscopy, represent a priority in screening programmes management.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Senore C, Basu P, Anttila A, et al. Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report. Gut. 2018. PMID: 30530530. doi:10.1136/gutjnl-2018-317293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。